Absorption, Distribution, Metabolism, and Excretion of Revefenacin, a Long-Acting Muscarinic Antagonist (LAMA), in Healthy Male Subjects

被引：0
|
作者：
Bourdet, D. [1 ]
Yeola, S. [1 ]
Colson, P. [1 ]
Pendyala, S. [1 ]
Barnes, C. N. [1 ]
Borin, M. [1 ]
机构：
[1] Theravance Biopharma US Inc, San Francisco, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3033
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
    Oba, Yuji
    Sarva, Siva T.
    Dias, Sofia
    THORAX, 2016, 71 (01) : 15 - 25
  • [42] Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults
    Borges, Gina
    Fong, Reedmond Y.
    Ensunsa, Jodi L.
    Kimball, Jennifer
    Medici, Valentina
    Ottaviani, Javier I.
    Crozier, Alan
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 185 : 90 - 96
  • [43] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)
    Horita, Nobuyuki
    Goto, Atsushi
    Shibata, Yuji
    Ota, Erika
    Nakashima, Kentaro
    Nagai, Kenjiro
    Kaneko, Takeshi
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (02):
  • [44] ABSORPTION AND EXCRETION OF SULFAMETHOXYPYRIDAZINE - A NEW, LONG-ACTING ANTIBACTERIAL SULFONAMIDE
    NICHOLS, RL
    FINLAND, M
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1957, 49 (03): : 410 - 421
  • [45] EXCRETION AND METABOLISM OF LONG-ACTING NEUROLEPTIC DRUG FLUSPIRILENE IN RAT
    HEYKANT.JPP
    LIFE SCIENCES PART 1 PHYSIOLOGY AND PHARMACOLOGY AND PART 2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1969, 8 (19P1): : 1029 - &
  • [46] Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
    Oba, Yuji
    Chandran, Arul V.
    Devasahayam, Joe V.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (06) : 677 - 685
  • [47] Clinical Efficacy of Long-Acting β2 Agonists and Long-Acting Muscarinic Antagonist for Moderate to Severe Chronic Obstructive Pulmonary Disease
    Yongqian Xu
    Yu Pang
    Pharmaceutical Chemistry Journal, 2023, 57 : 365 - 372
  • [48] Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis
    Tungnantawiwat, Metinee
    Kitinarong, Kamon
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [49] Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combinations Compare to Long-Acting β-Agonist/Inhaled Corticosteroid Combinations: A Network Meta-Analysis
    Ahmed, T. Said
    Al-Sarie, M.
    Srour, K.
    Rygielski, S.
    Ye, F.
    Hernandez, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [50] ABSORPTION, DISTRIBUTION, METABOLISM, AND ELIMINATION OF RADIOLABELED XANOMELINE IN HEALTHY MALE-SUBJECTS
    DELONG, AF
    BONATE, PL
    GILLESPIE, T
    HENRY, DP
    SATTERWHITE, JH
    NEUROBIOLOGY OF AGING, 1994, 15 : S105 - S105
12345